Jamaica: Agricultural Biotechnology Annual

  |   Attaché Report (GAIN)

Jamaica is an important market for U.S. bulk agricultural products, intermediate products and high value products, with a total value of approximately USD 378 million in 2017. In Jamaica, there is currently no commercial production of genetically engineered (GE) crops. In addition, Jamaica does not have a biotechnology or biosafety legal framework for the deregulation or commercialization of biotechnology crops and does not have specific requirements for GE imports. There are current regulations that governs the importation of GE products for experimental purposes. In addition, Jamaica’s draft biotechnology policy, which has been in draft form for several years, explicitly states the need for mandatory labeling of GE products.  

Jamaica: Agricultural Biotechnology Annual

New Technologies
Western Hemisphere, Jamaica

Database Source:

Related Reports

View More
Attaché Report (GAIN)

Ukraine: Biotechnology and Other New Production Technologies Annual

The biotechnology regulatory system in Ukraine is still not fully developed, but the country is gradually adjusting its domestic policies to align with European Union regulations.
Attaché Report (GAIN)

Tunisia: Agricultural Biotechnology Annual

Tunisia is continuing to postpone non-urgent matters in front of major political and economic reforms. As a result, Tunisia’s biosafety framework, which was drafted in 2014, remains on hold with no timeframe for a review and parliamentary vote.
Attaché Report (GAIN)

Thailand: Rice Price - Weekly

Export prices of white and parboiled rice rose one percent from the previous week as exporters reportedly continued to secure the rice supplies to fulfill contract shipments.